| Fuchslueger, Ulf (Vialis AG 201105 CEO) |
Chief Executive Officer (CEO) |
Vialis (Group) |
Switzerland |
| Fudge, Ann |
Board member, non-executive |
Novartis (Group) |
Switzerland |
| Fuenzalida, Fernando (Endress+Hauser 2012–201705 Supervisory Board Member before CFO 1998–2012) |
Supervisory Board Member |
Endress+Hauser (Group) |
Switzerland |
| Fuhge, Peter |
n. a. |
Affimed (Group) |
Germany |
| Fuhr, Günter R. (Fraunhofer 201402 Head of Fraunhofer IBMT) |
Professor |
Fraunhofer (Group) |
Germany |
| Fuhrer, David (Neopharm Group (IL) 201307 CEO + Owner) |
Chief Executive Officer (CEO) |
Neopharm (IL) (Group) |
Israel |
| Fulpius, Nicolas (Affentranger Associates 200803 Partner before Ultreia Capital Investment Director) |
Partner (venture partner) |
Affentranger Associates S.A. |
Switzerland |
| Funk, Günter (Mikromol 200503 founder) |
Company Founder |
LGC (Group) |
Germany |
| Funk, Marc (Lonza 201903 CEO before COO of Pharma&Biotech division joined Lonza 1/09) |
Chief Operating Officer (COO) |
Lonza Group (Group) |
Switzerland |
| Furch, Marcus (Rodos BioTarget 200905 CEO) |
Chief Executive Officer (CEO) |
Rodos BioTarget GmbH |
Germany |
| Furmanski, Laura (Qiagen 2014–201711 Head of Bioinformatics Business Area RESIGNED END 2017) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Germany |
| Furst, David (Mediq Innovation Experts LLC 201707 Managing Partner befoer LifeSci + GILSC 201109) |
Managing Partner |
Mediq Innovation Experts (Group) |
Israel |
| Futch, Clarke B. (HealthCare Royalty Partners 201409 founding Managing Director) |
Managing Director |
HealthCare Royalty Partners (HC Royalty) |
United States (USA) |
| Fünfschilling, Hans (früher Roche) |
Governmental Officer (personnel) |
Switzerland (govt) |
Switzerland |
| Fürmeier, Sven (Univ Kassel 200908 Institute for Chemistry, Mass Spectrometry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Kassel |
Germany |
| Fürstenberg-Brock (Deutsche Messe 201009 Projektleiter Biotechnica) |
Event Manager / Conference Manager |
Deutsche Messe AG |
Germany |
| Fürstner, Alois (Max Planck 1993– MPI for Coal Research Mühlheim) |
Professor |
Max Planck Society for the Advancement of Science |
|
| Fäh, Urban (Bruker Corp 201802 President of Bruker Optics) |
President/Director/Head Business Group/Unit/Division |
Bruker BioSciences (Group) |
|
| Färber, Nico (Thermo Fisher 201710 Patheon Business Development Executive Pharma Services) |
Business Development Manager / Strategy Manager |
Thermo Fisher (Group) |
Canada |
| Fäs, Stefan (BioMedPartners 201702 CFO) |
Chief Financial Officer (CFO) |
BioMedPartners (Group) |
Switzerland |
| Fässler, Christoph (Metrohm 201107 CEO) |
Chief Executive Officer (CEO) |
Metrohm (Group) |
Switzerland |
| Föll, Armin (GC biotech 200809) |
n. a. |
GC biotech (Group) |
Germany |
| Förster, Hans-Heinrich (Genolytic 201109 Managing Director) |
Managing Director |
Genolytic GmbH |
Germany |
| Förtsch, Bernd (BF Holding) |
Managing Director |
BF Holding (Group) |
Germany |
| Gaal, Lubor (Locust Walk 201807– SVP + Head of Europe before Almirall + BMS + Neuro3d + Vectron Therapeutics) |
Consultant (economic/technology) |
Locust Walk (Group) |
United Kingdom (GB) |
| Gabel, Detlef (Univ Bremen 200911 Prof Organic Chemistry + Kooperationszentrum Medizin) |
Professor |
University of Bremen |
Germany |
| Gabert, Jörg (Priontype 200602 Managing Director) |
Managing Director |
Qiagen (Group) |
Germany |
| Gabor, E. Allan (Merck (DE) 201801 MAnaging Director + Country Speaker China joined 2013 before Pfizer China) |
Regional manager |
Merck (DE) (Group) |
Germany |
| Gabriel, Raimund (MC Services 1999–201101– Founder + CEO) |
Chief Executive Officer (CEO) |
MC Services AG |
Germany |
| Gabriel, Sigmar (Germany (govt) 2014 Minister of Economic Affairs and Energy) |
Minister |
Germany (govt) |
Germany |
| Gabrielczyk, Thomas |
n. a. |
Biocom (Group) |
Germany |
| Gadicke, Ansbert (MPM Capital 201604 Bioventure Investment Manager + Co-Founder) |
Investment Manager |
MPM Capital (Group) |
United States (USA) |
| Gahlmann, Reinhold (Biofrontera 200601– Managing Director before 15y Bayer Pharma AG) |
Managing Director |
Biofrontera (Group) |
Germany |
| Gaillard, Pierre (Servier 201702 Director of Global Marketing) |
Sales Manager / Marketing Manager |
Servier (Group) |
France |
| Gaillard, Pieter J. (to-BBB 200902– CSO before CEO) |
Chief Executive Officer (CEO) |
2-BBB Medicines (Group) |
Netherlands |
| Gaissmaier, Christoph (B Braun 201307 Executive Manager) |
Board member, executive |
B. Braun (Group) |
Germany |
| Galbraith, Daniel (BioOutsource 201402 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sartorius (Group) |
United Kingdom (GB) |
| Galbraith, Susan (AstraZeneca 201212 VP + Head Oncology Innovative Medicines Unit) |
President/Director/Head Business Group/Unit/Division |
AstraZeneca (Group) |
United Kingdom (GB) |
| Galdos, Aitor (Tecan 2003–200412 CEO left because of differences over operational management with Board) |
Chief Executive Officer (CEO) |
Tecan (Group) |
Switzerland |
| Gale, James (Signet Healthcare Partners 201507 Managing Director) |
Managing Director |
Signet Healthcare Partners (US) |
United States (USA) |
| Gales, Ann (A Gales Consulting 201709 Managing Partner) |
Managing Partner |
A Gales Consulting Ltd. |
United Kingdom (GB) |
| Galfetti, Paolo (APR Applied Pharma Research 201505 CEO) |
Chief Executive Officer (CEO) |
APR Applied Pharma Research S.A. |
Switzerland |
| Gall, Karsten (Ionovation 201206 Managing Director) |
Managing Director |
Ionovation GmbH |
Germany |
| Gallagher, Stephen (Dotmatics 200612 CEO) |
Chief Executive Officer (CEO) |
Dotmatics (Group) |
United Kingdom (GB) |
| Galli, Roberto (Newron 201504 VP Finance) |
Chief Financial Officer (CFO) |
Newron (Group) |
Italy |
| Galon, Jérôme (INSERM 201507 + Co-Founder of HalioDx) |
Researcher (university / research institute) |
France (govt) |
France |
| Galuschka, Nicole (MC Services 201705) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Galvin, Bob (Bruker Corp 201411 VP Biopharmaceutical Business Unit) |
President/Director/Head Business Group/Unit/Division |
Bruker Corporation (Group) |
United States (USA) |
| Gamber, Michael (Merck (DE) 201507 Head of Merck Innovation Center) |
n. a. |
Merck (DE) (Group) |
Germany |
| Gambillara Fonck, Veronica (LimmaTech Biologics 201508 Managing Director) |
Managing Director |
LimmaTech Biologics AG |
Switzerland |
| Gamer, Jürgen (Apogenix 200810 VP BusDev) |
Business Development Manager / Strategy Manager |
Apogenix GmbH |
Germany |
| Gammack, Jason T. (Qiagen 201503 VP Qiagen Advanced Genomics + Head Global Commercial Operations) |
Chief Commercial Officer (CCO) |
Qiagen (Group) |
Germany |
| Ganal, Martin (TraitGenetics GmbH 2000– Managing Director + Founder) |
Managing Director |
SGS (Group) |
Germany |
| Ganten, Detlev |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Ganyushin, Albert (Euronext 201511 Head of International Listings) |
n. a. |
Euronext (Group) |
Netherlands |
| Garaguso, Ignazio (Omnilab 201202 Product Specialist Chromatography Service) |
n. a. |
Omnilab (DE) (Group) |
Germany |
| Garaud, Jean-Jacques (Inotrem 201403 CEO before Roche –201206 Global Head pRED) |
President/Director/Head Business Group/Unit/Division |
Inotrem S.A. |
France |
| Gardner, Chris (Consilium 201507– Partner before since 2003 at Citigate Dewe Rogerson London) |
Public Relations Manager / Investor Relations Manager |
Consilium Strategic Communications Ltd. (CSC) |
United Kingdom (GB) |
| Gardner, Jason (Magenta Therapeutics 201611 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Magenta Therapeutics Inc. |
United States (USA) |
| Garguilo, Pia (Qiagen 201004– Senior Director Pharma Business Development before AstraZenca LP) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
| Garijo, Belén (Merck (DE) 201310– CEO of Merck Serono before COO sinc 2011 before Sanofi) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
| Garnebode, Nils (Shimadzu 201404 Head Product Support + Marketing at Shimadzu Deutschland Gmb) |
Sales Manager / Marketing Manager |
Shimadzu Deutschland GmbH |
Germany |
| Garnier, Jean-Pierre (Pierre Fabre Labs 2008–2010 CEO before GSK 2001–2008 CEO before SmithKline Beecham CEO) |
Chief Executive Officer (CEO) |
GlaxoSmithKline (GSK) (Group) |
United Kingdom (GB) |
| Garotti, Alberto (JSR Corp 201801– CFO of Selexis SA before Coty Inc + Unilever) |
Chief Financial Officer (CFO) |
JSR Corporation (Group) |
Switzerland |
| Garrett, Dave (Nabriva 201709 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Nabriva (Group) |
Austria |
| Garthoff, Bernward (Nordrhein-Westfalen (govt) 2010 Head of BIO.NRW before Bayer CropScience 200506) |
Business Development Manager / Strategy Manager |
Nordrhein-Westfalen (govt region) |
Germany |
| Gasteiger, Johann (Univ Erlangen-Nuremberg 1994–) |
Company Founder |
University of Erlangen-Nuremberg (Friedrich Alexander University, FAU) |
Germany |
| Gates, William Henry (Bill), III |
n. a. |
Bill and Melinda Gates Foundation |
United States (USA) |
| Gatter, Jochen (AnalytiCon Discovery GmbH 2007) |
n. a. |
BRAIN (Group) |
Germany |
| Gatzemeier, Susanne (Global Fairs 201504) |
n. a. |
Global Fairs (FR) |
France |
| Gauer, Christoph (Olympus 200901 before Advalytix 200011– co-founder + CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
Germany |
| Gausepohl, Herr (Intavis 200809) |
Sales Manager / Marketing Manager |
HB Technologies (Group) |
Germany |
| Gavlas, Jozef (Medirex Group 201801 CEO) |
Chief Executive Officer (CEO) |
Medirex Group (CZ/SK) |
Slovak Republic (Slovakia) |
| Gaweco, Anderson (Apeiron 201808– CMSO before Innovimmune Biotherapeutics + Lifecycle Pharma + Roche + Pfizer) |
Chief Medical Officer (CMO) |
Apeiron (Group) |
Austria |
| Gdynia, Georg (EnFin GmbH 201707– Managing Director) |
Managing Director |
EnFin GmbH |
Germany |
| Gebauer, Alexander (Omeicos 201804– Executive Board Member + CEO of Omeicos Ophthalmics before Sun Pharma + Ranbaxy) |
Chief Executive Officer (CEO) |
Omeicos (Group) |
United States (USA) |
| Gebauer, Michael (Cardiac Research GmbH 201209 Managing Director + Cortag GmbH Managing Director) |
Managing Director |
Cardiac Research GmbH |
Germany |
| Gedeon, Nora (QPS 201404 Director Business Development Clinical Research at QPS Austria GmbH) |
Business Development Manager / Strategy Manager |
QPS (Group) |
Austria |
| Gedig, Erk (XanTec Bioanalytics 201108 Managing Director) |
Managing Director |
XanTec Bioanalytics GmbH |
Germany |
| Geerds, Arno (Ribocon 2005– co-founder + managing director) |
Managing Director |
Ribocon GmbH |
Germany |
| Gehlsen, Kurt R. (Research Corporation Technologies 201412 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
RCT (Group) |
United States (USA) |
| Gelber, Jeremy (Pamplona Capital 201706 Partner) |
Chief Executive Officer (CEO) |
Parexel (Group) |
United States (USA) |
| Gelbke, Franz (Norgenta 200602) |
n. a. |
Hamburg (govt region) |
Germany |
| Geller, Matthew (Geller Biopharm 2008– Managing Director + Founder before Rodman + Renshaw) |
Managing Director |
Geller Biopharm Inc. |
United States (USA) |
| Geller, Patricia (Qiagen 2009 Director Corporate Strategy) |
Corporate Strategy Manager |
Qiagen (Group) |
Germany |
| Gelone, Steven (Nabriva 20707– promoted COO joined 201412 before Spark Therapeutics + ViroPharma) |
Chief Operating Officer (COO) |
Nabriva (Group) |
Austria |
| Gent, Ricardo (DIB 200503 Managing Director) |
Managing Director |
VCI (Verband der Chemischen Industrie e. V.) |
Germany |
| Genth, Peter |
n. a. |
FIZ Technik (Group) |
Germany |
| Gentz, Torben (Helmholtz 200908 Alfred Wegener Institute) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Geoghegan-Quinn, Máire (EU (govt) 201103 Commissioner for Research, Innovation and Science) |
Administrative Officer (personnel) |
EU (govt) |
Belgium |
| George, Jeff (Novartis 201404– Divison Head of Alcon before Division Head of Sandoz) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
| George, Martine (GPC Biotech 200604– Senior VP + CMO) |
Chief Medical Officer (CMO) |
HOPP Group (family of Dietmar Hopp) |
Germany |
| George, Peter (Clinigen Group 201303 CEO) |
Chief Executive Officer (CEO) |
Clinigen Group plc |
United Kingdom (GB) |
| George, Simeon (GSK 201504 SR One) |
Investment Manager |
GlaxoSmithKline (GSK) (Group) |
United States (USA) |
| Gerber, Fritz (200808 before Roche CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
Switzerland |
| Gerdes, Friedericke (Epigenomics 200811– Head Marketing before Agendia) |
Sales Manager / Marketing Manager |
Epigenomics (Group) |
Germany |
| Gericke, Dieter (Homburger 201512 Partner Corporate & M&A) |
Attorney / Lawyer |
Homburger AG |
Switzerland |
| Gerin, Sébastian (Cytel 201710 SVP Strategy + Performance) |
Business Development Manager / Strategy Manager |
Cytel (Group) |
United States (USA) |
| Gerlach, Ernst (NRW.Bank 200607 CEO) |
Chief Executive Officer (CEO) |
Nordrhein-Westfalen (govt region) |
Germany |
| Gerlach, Herwig (Klinikum Neukölln Berlin 200606 Prof) |
Professor |
Humboldt University Berlin |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 17 18 19 ... 65 66 67 
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lsus-life-sciences-usa-com-beta.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
